In this article, the authors lead a case from practice. Given the clinical and hormonal characteristics, as well as specific changes according to MRI, the diagnosis of "congenital hypopituitarism" did not cause doubt. After the purpose of the chorionic gonadotropin of 1500 units 2 times a week for 2 months, there was a positive dynamics from the genital organs.
Ismailov, S. I., Kulmirzaeva, M. G., Urmanova, Yu. M., & Gilazitdinov, K. N. (2019). Constitutional height delay and Pubertata in boys: Review of Literature. International Endocrinological Journal, 15 (5).
Dedov, I. I., Melnichenko, G. A., & Fadeev, V. V. (2009). Endocrinology. M.: "Gootar-Media".
Degtyarova, A.V., Mukhina, Yu. G., & Degtyarev, D. N. (2011). Cholestaz syndrome in newborns. Manual for doctors. M.: Scientific Center for Obstetrics, Gynecology and Perinatology. Vi Kulakova, Russian Medical University. Neither Pirogov.
Khojaeva, F. S., Urmanova, Yu. M., & Rhisieva, N. T. (2015). The case of a combination of hypoplasia pituitary and achondroplasia in a six-year-old boy. International Endocrinological Journal, (1 (65)).
Antoniazzi, F., Cavarzere, P., & Gaudino, R. (2015). Growth hormone and early treatment. Minerva Endocrinol, 40(2), 129-143.
Braslavsky, D., Keselman, A., Galoppo, M., Lezama, C., Chiesa, A., Galoppo, C., & Bergadá, I. (2011). Neonatal cholestasis in congenital pituitary hormone deficiency and isolated hypocortisolism: characterization of liver dysfunction and follow-up. Arquivos Brasileiros de Endocrinologia & Metabologia, 55(8), 622-627.
Cardoso, D. F., Martinelli Jr, C. E., Campos, V. C., Gomes, E. S., Rocha, Í. E., Oliveira, C. R., ... & Aguiar-Oliveira, M. H. (2014). Comparison between the growth response to growth hormone (GH) therapy in children with partial GH insensitivity or mild GH deficiency. Arquivos Brasileiros de Endocrinologia & Metabologia, 58(1), 23-29.
Grimberg, A., DiVall, S. A., Polychronakos, C., Allen, D. B., Cohen, L. E., Quintos, J. B., ... & Murad, M. H. (2016). Drug and Therapeutics Committee and Ethics Committee of the Pediatric Endocrine Society. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr, 86(6), 361-397.
Kelberman, D., Turton, J. P. G., Woods, K. S., Mehta, A., Al‐Khawari, M., Greening, J., ... & Dattani, M. T. (2009). Molecular analysis of novel PROP1 mutations associated with combined pituitary hormone deficiency (CPHD). Clinical endocrinology, 70(1), 96-103.
Lammoglia, J. J., Eyzaguirre, F., Unanue, N., Roman, R., Codner, E., Cassorla, F., & Mericq, V. (2008). Congenital hypopituitarism: report of 23 cases. Revista medica de Chile, 136(8), 996-1006.
Navardauskaite, R., Dusatkova, P., Obermannova, B., Pfaeffle, R. W., Blum, W. F., Adukauskiene, D., ... & Lebl, J. (2014). High prevalence of PROP1 defects in Lithuania: phenotypic findings in an ethnically homogenous cohort of patients with multiple pituitary hormone deficiencies. The Journal of Clinical Endocrinology & Metabolism, 99(1), 299-306.
Pawlikowska-Haddal, A. (2013). Growth hormone therapy with norditropin (somatropin) in growth hormone deficiency. Expert opinion on biological therapy, 13(6), 927-932.